Feng, L.; Zhao, W.; Wang, J.; Lin, K.-Y.; Guo, Y.; Zhang, L.
Data-Driven Technology Roadmaps to Identify Potential Technology Opportunities for Hyperuricemia Drugs. Pharmaceuticals 2022, 15, 1357.
https://doi.org/10.3390/ph15111357
AMA Style
Feng L, Zhao W, Wang J, Lin K-Y, Guo Y, Zhang L.
Data-Driven Technology Roadmaps to Identify Potential Technology Opportunities for Hyperuricemia Drugs. Pharmaceuticals. 2022; 15(11):1357.
https://doi.org/10.3390/ph15111357
Chicago/Turabian Style
Feng, Lijie, Weiyu Zhao, Jinfeng Wang, Kuo-Yi Lin, Yanan Guo, and Luyao Zhang.
2022. "Data-Driven Technology Roadmaps to Identify Potential Technology Opportunities for Hyperuricemia Drugs" Pharmaceuticals 15, no. 11: 1357.
https://doi.org/10.3390/ph15111357
APA Style
Feng, L., Zhao, W., Wang, J., Lin, K.-Y., Guo, Y., & Zhang, L.
(2022). Data-Driven Technology Roadmaps to Identify Potential Technology Opportunities for Hyperuricemia Drugs. Pharmaceuticals, 15(11), 1357.
https://doi.org/10.3390/ph15111357